[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100522290":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":28,"centralContacts":35,"locations":43,"responsibleParty":248,"collaborators":250,"id":253,"slug":254,"hasResults":255,"nctId":256,"briefTitle":257,"officialTitle":257,"acronym":258,"eligibilityCriteria":259,"healthyVolunteers":255,"sex":260,"minAge":261,"maxAge":24,"enrollmentInfo":262,"targetDuration":24,"studyType":265,"phases":266,"briefSummary":268,"conditions":269,"keywords":271,"overallStatus":46,"whyStopped":24,"lastUpdateSubmitDate":279,"lastUpdatePostDateStruct":280,"startDateStruct":283,"completionDateStruct":285,"leadSponsor":287,"locationsCount":288},{"fullName":5,"class":6},"Johns Hopkins University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Intravenous Antibiotics","ACTIVE_COMPARATOR","IV antibiotics from the time of randomization to the completion of antibiotic treatment. Includes antibiotics such as ceftriaxone, cefepime, piperacillin-tazobactam, and meropenem.",[13],"Drug: Intravenous Antibiotics",{"label":15,"type":10,"description":16,"interventionNames":17},"Oral Antibiotics","Oral antibiotics from the time of randomization to the completion of antibiotic treatment, Includes antibiotics such as amoxicillin, cephalexin, ciprofloxacin, and trimethoprim-sulfamethoxazole.",[18],"Drug: Oral Antibiotics",[20,25],{"type":21,"name":9,"description":22,"armGroupLabels":23,"otherNames":24},"DRUG","Participants will continue to receive intravenous antibiotics until the completion of the treatment course",[9],null,{"type":21,"name":15,"description":26,"armGroupLabels":27,"otherNames":24},"Participants will transition to oral antibiotics at the time of randomization and will continue oral antibiotics until the completion of the treatment course",[15],[29,33],{"name":30,"affiliation":31,"role":32},"Pranita D Tamma, MD, MHS","Children's Hospital of Philadelphia","PRINCIPAL_INVESTIGATOR",{"name":34,"affiliation":5,"role":32},"Sara E Cosgrove, MD, MS",[36,40],{"name":30,"role":37,"phone":38,"phoneExt":24,"email":39},"CONTACT","410-614-1492","tammap1@chop.edu",{"name":34,"role":37,"phone":41,"phoneExt":24,"email":42},"443-287-4570","scosgro1@jhmi.edu",[44,66,85,104,118,136,154,172,190,208,228],{"facility":45,"status":46,"city":47,"state":48,"zip":49,"country":50,"countryCode":51,"cosmosGeoPoint":52,"geoPoint":57,"contacts":58},"University of California, San Francisco","RECRUITING","San Francisco","California","94143","United States","US",{"type":53,"coordinates":54},"Point",[55,56],-122.41942,37.77493,{"lat":56,"lon":55},[59,62,65],{"name":60,"role":37,"phone":24,"phoneExt":24,"email":61},"Sarah Doernberg, MD","sarah.doernberg@ucsf.edu",{"name":63,"role":37,"phone":24,"phoneExt":24,"email":64},"Mahroo Safaei","mahroo.safaei@ucsf.edu",{"name":60,"role":32,"phone":24,"phoneExt":24,"email":24},{"facility":67,"status":46,"city":68,"state":69,"zip":70,"country":50,"countryCode":51,"cosmosGeoPoint":71,"geoPoint":75,"contacts":76},"Denver Health Hospital Authority","Denver","Colorado","80204",{"type":53,"coordinates":72},[73,74],-104.9847,39.73915,{"lat":74,"lon":73},[77,80,83],{"name":78,"role":37,"phone":24,"phoneExt":24,"email":79},"Timothy Jerkins, MD","timothy.jenkins@dhha.org",{"name":81,"role":37,"phone":24,"phoneExt":24,"email":82},"Judy Oakes","judy.oakes@dhha.org",{"name":84,"role":32,"phone":24,"phoneExt":24,"email":24},"Tomothy Jerkins, MD",{"facility":86,"status":46,"city":87,"state":88,"zip":89,"country":50,"countryCode":51,"cosmosGeoPoint":90,"geoPoint":94,"contacts":95},"University of Maryland Medical Center","Baltimore","Maryland","21202",{"type":53,"coordinates":91},[92,93],-76.61219,39.29038,{"lat":93,"lon":92},[96,99,102],{"name":97,"role":37,"phone":24,"phoneExt":24,"email":98},"Anthony Harris","aharris@som.umaryland.edu",{"name":100,"role":37,"phone":24,"phoneExt":24,"email":101},"Michelle Newan","mnewman@som.umaryland.edu",{"name":103,"role":32,"phone":24,"phoneExt":24,"email":24},"Anthony Harris, MD",{"facility":105,"status":46,"city":87,"state":88,"zip":106,"country":50,"countryCode":51,"cosmosGeoPoint":107,"geoPoint":109,"contacts":110},"Johns Hopkins University Hospital Systems","21287",{"type":53,"coordinates":108},[92,93],{"lat":93,"lon":92},[111,113,116],{"name":112,"role":37,"phone":41,"phoneExt":24,"email":42},"Sara Cosgrove",{"name":114,"role":37,"phone":24,"phoneExt":24,"email":115},"Alyssa Cavezza","acavezz1@jh.edu",{"name":117,"role":32,"phone":24,"phoneExt":24,"email":24},"Michael Melia, MD",{"facility":119,"status":46,"city":120,"state":121,"zip":122,"country":50,"countryCode":51,"cosmosGeoPoint":123,"geoPoint":127,"contacts":128},"Mayo Clinic","Rochester","Minnesota","55905",{"type":53,"coordinates":124},[125,126],-92.4699,44.02163,{"lat":126,"lon":125},[129,132,135],{"name":130,"role":37,"phone":24,"phoneExt":24,"email":131},"Gina Suh, MD","suh.gina@mayo.edu",{"name":133,"role":37,"phone":24,"phoneExt":24,"email":134},"Jacob Bjerke","bjerke.jacob@mayo.edu",{"name":130,"role":32,"phone":24,"phoneExt":24,"email":24},{"facility":137,"status":46,"city":138,"state":139,"zip":140,"country":50,"countryCode":51,"cosmosGeoPoint":141,"geoPoint":145,"contacts":146},"Rutgers-RWJ University Hospital","New Brunswick","New Jersey","08901",{"type":53,"coordinates":142},[143,144],-74.45182,40.48622,{"lat":144,"lon":143},[147,150,153],{"name":148,"role":37,"phone":24,"phoneExt":24,"email":149},"Keith Kaye, MD","kk1116@rwjms.rutgers.edu",{"name":151,"role":37,"phone":24,"phoneExt":24,"email":152},"Swati Kumar","sk2280@rwjms.rutgers.edu",{"name":148,"role":32,"phone":24,"phoneExt":24,"email":24},{"facility":155,"status":46,"city":156,"state":157,"zip":158,"country":50,"countryCode":51,"cosmosGeoPoint":159,"geoPoint":163,"contacts":164},"Duke University","Durham","North Carolina","27710",{"type":53,"coordinates":160},[161,162],-78.89862,35.99403,{"lat":162,"lon":161},[165,168,171],{"name":166,"role":37,"phone":24,"phoneExt":24,"email":167},"Joshua Thaden, MD","joshua.thaden@duke.edu",{"name":169,"role":37,"phone":24,"phoneExt":24,"email":170},"Laura Farrow","laura.farrow@duke.edu",{"name":166,"role":32,"phone":24,"phoneExt":24,"email":24},{"facility":173,"status":46,"city":174,"state":175,"zip":176,"country":50,"countryCode":51,"cosmosGeoPoint":177,"geoPoint":181,"contacts":182},"Hospital of the University of Pennsylvania","Philadelphia","Pennsylvania","19104",{"type":53,"coordinates":178},[179,180],-75.16362,39.95238,{"lat":180,"lon":179},[183,186,189],{"name":184,"role":37,"phone":24,"phoneExt":24,"email":185},"Lauren Dutcher, MD","dutcherl@pennmedicine.upenn.edu",{"name":187,"role":37,"phone":24,"phoneExt":24,"email":188},"Pam Tolomeo","tolomeop@pennmedicine.upenn.edu",{"name":184,"role":32,"phone":24,"phoneExt":24,"email":24},{"facility":191,"status":46,"city":192,"state":193,"zip":194,"country":50,"countryCode":51,"cosmosGeoPoint":195,"geoPoint":199,"contacts":200},"Vanderbilt University Medical Center","Nashville","Tennessee","37232",{"type":53,"coordinates":196},[197,198],-86.78444,36.16589,{"lat":198,"lon":197},[201,204,207],{"name":202,"role":37,"phone":24,"phoneExt":24,"email":203},"George Nelson, MD","george.nelson@vumc.org",{"name":205,"role":37,"phone":24,"phoneExt":24,"email":206},"Marina Khalil","marina.khalil@vumc.org",{"name":202,"role":32,"phone":24,"phoneExt":24,"email":24},{"facility":209,"status":46,"city":210,"state":211,"zip":212,"country":50,"countryCode":51,"cosmosGeoPoint":213,"geoPoint":217,"contacts":218},"Houston Methodist","Houston","Texas","77030",{"type":53,"coordinates":214},[215,216],-95.36327,29.76328,{"lat":216,"lon":215},[219,223,226],{"name":220,"role":37,"phone":221,"phoneExt":24,"email":222},"William L Musick, Pharm D","281-222-9983","mwadelman@houstonmethodist.org",{"name":224,"role":37,"phone":24,"phoneExt":24,"email":225},"Jennifer Garrett","jmgarrett@houstonmethodist.org",{"name":227,"role":32,"phone":24,"phoneExt":24,"email":24},"William L Musick, PharmD",{"facility":229,"status":46,"city":230,"state":231,"zip":232,"country":50,"countryCode":51,"cosmosGeoPoint":233,"geoPoint":237,"contacts":238},"Carilion Clinic","Roanoke","Virginia","24011",{"type":53,"coordinates":234},[235,236],-79.94143,37.27097,{"lat":236,"lon":235},[239,243,246],{"name":240,"role":37,"phone":241,"phoneExt":24,"email":242},"Lana Wahid","757-509-8162","lwahid@carilionclinic.org",{"name":244,"role":37,"phone":24,"phoneExt":24,"email":245},"Parisa Farahani","pfarahani@carlionclinic.org",{"name":247,"role":32,"phone":24,"phoneExt":24,"email":24},"Lana Wahid, MD",{"type":249,"investigatorFullName":24,"investigatorTitle":24,"investigatorAffiliation":24,"oldNameTitle":24,"oldOrganization":24},"SPONSOR",[251],{"name":252,"class":6},"Patient-Centered Outcomes Research Institute","100522290","gram-negative-bloodstream-infection-oral-antibiotic-therapy-trial-100522290",false,"NCT06080698","Gram-Negative Bloodstream Infection Oral Antibiotic Therapy Trial","GOAT","Inclusion Criteria:\n\n* Adult (≥ 18 years) at the time of screening\n* Hospitalized\n* Identification of at least one Gram-negative organism in a blood culture\n* Capable of providing written informed consent (includes through a legally authorized representative)\n* Willingness to adhere to assigned study arm\n* Capable and willing to complete a follow-up QoL interview (including through a legally authorized representative)\n\nExclusion Criteria:\n\n* Unable to tolerate or absorb a course of oral antibiotics\n* Actively receiving vasopressors\n* Gram-negative organism not susceptible to any oral antibiotics\n* Gram-negative organism not susceptible to any IV antibiotics\n* Polymicrobial bloodstream infection\n\n  * The following patients with polymicrobial infections remain eligible for enrollment: (1) more than one morphology or species of a gram-negative organism (except for Acinetobacter baumannii or Stenotrophomonas maltophilia), (2) a single positive blood culture with a common commensal organism (grown in addition to an Enterobacterales species or Pseudomonas aeruginosa\n* Allergy or contraindication rendering no oral option or no IV option for therapy with the listed antibiotic agents.\n* Anticipated duration of therapy greater than 14 days\n* Central nervous system infection\n* Absolute neutrophil count of \\\u003C500 cells\u002FmL or anticipated to reduce to \\\u003C500 cells\u002FmL during the antibiotic treatment course.\n* Receiving hospice care","ALL","18 Years",{"count":263,"type":264},1030,"ESTIMATED","INTERVENTIONAL",[267],"NA","The Gram-negative bloodstream infection Oral Antibiotic Therapy trial (The GOAT Trial) is a multi-center, randomized clinical trial that hypothesizes that early transition to oral antibiotic therapy for the treatment of Gram-Negative BloodStream Infection (GN-BSI) is as effective but safer than remaining on intravenous (IV) antibiotic therapy for the duration of treatment.",[270],"Gram-negative Bacteremia",[272,273,274,275,276,277,278],"Gram-negative bacteremia","Antibiotic treatment","Antibiotic route","Escherichia coli","Pseudomonas aeruginosa","Klebsiella pneumoniae","Desirability of outcome ranking (DOOR)","2026-03-09",{"date":281,"type":282},"2026-03-11","ACTUAL",{"date":284,"type":282},"2024-02-22",{"date":286,"type":264},"2027-06-30",{"name":5,"class":6},11]